Logo Logo
Group by: Item Type | Date
Jump to: 2023 | 2022
Number of items: 4.


Bücklein, Veit; Perez, Ariel; Rejeski, Kai; Iacoboni, Gloria; Jurinovic, Vindi; Holtick, Udo; Penack, Olaf; Kharboutli, Soraya; Blumenberg, Viktoria; Ackermann, Josephine; Frölich, Lisa; Johnson, Grace; Patel, Kedar; Arciola, Brian; Mhaskar, Rahul; Wood, Anthony; Schmidt, Christian; Albanyan, Omar; Gödel, Philipp; Hoster, Eva ORCID logoORCID: https://orcid.org/0000-0002-0749-1389; Bullinger, Lars; Mackensen, Andreas; Locke, Frederick; Bergwelt-Baildon, Michael von ORCID logoORCID: https://orcid.org/0000-0002-1952-052X; Barba, Pere; Subklewe, Marion and Jain, Michael D. (2023): Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use. In: HemaSphere, Vol. 7, No. 8, e907

Blumenberg, Viktoria ORCID logoORCID: https://orcid.org/0000-0003-1379-0876; Galina, Busch; Baumann, Stephan ORCID logoORCID: https://orcid.org/0009-0001-2804-2072; Jitschin, Regina; Iacoboni, Gloria ORCID logoORCID: https://orcid.org/0000-0003-0805-9288; Hoster, Eva ORCID logoORCID: https://orcid.org/0000-0002-0749-1389; Gallur, Laura ORCID logoORCID: https://orcid.org/0000-0001-6293-9281; Iraola-Truchuelo, Josu ORCID logoORCID: https://orcid.org/0000-0002-9909-3715; Winkelmann, Michael; Hellwig, Konstantin ORCID logoORCID: https://orcid.org/0000-0001-9001-2176; Schmidt, Christian; Frölich, Lisa; Tast, Benjamin; Hildebrand, Friederike; Rejeski, Kai; Dekorsy, Franziska J.; Schmidkonz, Christian; Bäuerle, Tobias; Kunz, Wolfgang G. ORCID logoORCID: https://orcid.org/0000-0002-5021-1952; Mougiakakos, Dimitrios ORCID logoORCID: https://orcid.org/0000-0002-2817-6660; Müller, Fabian ORCID logoORCID: https://orcid.org/0000-0001-5487-5839; von Bergwelt-Baildon, Michael; Barba, Pere; Bücklein, Veit L. ORCID logoORCID: https://orcid.org/0000-0001-7391-7280; Mackensen, Andreas ORCID logoORCID: https://orcid.org/0000-0002-0685-4483; Völkl, Simon and Subklewe, Marion ORCID logoORCID: https://orcid.org/0000-0003-3905-0251 (2023): Early quantification of anti-CD19 CAR T-cells by flow cytometry predicts response in R/R DLBCL. In: Blood Advances, Vol. 7, No. 22: pp. 6844-6849 [PDF, 498kB]

Rejeski, Kai ORCID logoORCID: https://orcid.org/0000-0003-3905-0251; Wang, Yucai ORCID logoORCID: https://orcid.org/0000-0002-1576-8341; Albanyan, Omar; Munoz, Javier; Sesques, Pierre ORCID logoORCID: https://orcid.org/0000-0001-8264-822X; Iacoboni, Gloria; Lopez‐Corral, Lucia; Ries, Isabelle; Bücklein, Veit L.; Mohty, Razan; Dreyling, Martin; Baluch, Aliyah; Shah, Bijal ORCID logoORCID: https://orcid.org/0000-0003-4328-6021; Locke, Frederick L.; Hess, Georg; Barba, Pere; Bachy, Emmanuel; Lin, Yi; Subklewe, Marion ORCID logoORCID: https://orcid.org/0000-0001-9154-9469 and Jain, Michael D. ORCID logoORCID: https://orcid.org/0000-0002-7789-1257 (2023): The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL. In: American Journal of Hematology, Vol. 98, No. 11: pp. 1699-1710 [PDF, 2MB]


Rejeski, Kai ORCID logoORCID: https://orcid.org/0000-0003-3905-0251; Perez, Ariel; Iacoboni, Gloria; Penack, Olaf; Bücklein, Veit; Jentzsch, Liv; Mougiakakos, Dimitrios; Johnson, Grace; Arciola, Brian; Carpio, Cecilia; Blumenberg, Viktoria; Hoster, Eva ORCID logoORCID: https://orcid.org/0000-0002-0749-1389; Bullinger, Lars; Locke, Frederick L; Bergwelt-Baildon, Michael von ORCID logoORCID: https://orcid.org/0000-0002-1952-052X; Mackensen, Andreas; Bethge, Wolfgang; Barba, Pere; Jain, Michael D ORCID logoORCID: https://orcid.org/0000-0002-7789-1257 and Subklewe, Marion (2022): The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL. In: Journal for ImmunoTherapy of Cancer, Vol. 10, e004475 [PDF, 5MB]

This list was generated on Sun May 19 06:33:35 2024 CEST.